离体
青蒿素
肠道菌群
生物
透视图(图形)
计算生物学
体内
微生物学
免疫学
生物技术
计算机科学
疟疾
人工智能
恶性疟原虫
作者
Paulo Wender Portal Gomes,Helena Mannochio-Russo,Stanislav N. lablokov,Dmitry A. Rodionov,Heejung Yang,Pieter C. Dorrestein,Scott N. Peterson,Christine Tara Peterson
出处
期刊:ACS omega
[American Chemical Society]
日期:2025-05-15
卷期号:10 (21): 21929-21938
标识
DOI:10.1021/acsomega.5c01983
摘要
Artemisia is a plant genus historically used in Ayurveda and traditional Chinese medicine for its diverse pharmacological properties. Among the many phytochemicals found in Artemisia species, artemisinin is notable for its antimalarial activity. This compound is commonly isolated from Artemisia annua and is known to be biotransformed by fungi such as Aspergillus. However, there is limited knowledge on whether the gut microbiota can mediate artemisinin's biotransformation. To address this gap, this study explores for the first time the association between human gut microbiota and artemisinin-derived metabolites across three Artemisia species herbal extracts and purified artemisinin. Our findings describe the first sulfated artemisinin (C3H6NO3S) potentially modified by bacteria Romboutsia sedimentorum and Citrobacter freundii. Thus, we highlight how a multiomics approach to natural products can reveal interactions between Artemisia species and the gut microbiota. This understanding can enhance the knowledge of artemisinin metabolism in the human gut and contribute to the development of novel, effective therapeutic strategies.
科研通智能强力驱动
Strongly Powered by AbleSci AI